BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

[Coronavirus] Celltrion goes ino second stage of experiment to find medicine

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : April 2, 2020, 18:17 | Updated : April 2, 2020, 18:17
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Celltrion]


SEOUL -- Celltrion, a South Korean bio firm involved in a project to develop preventive vaccines and medicine for the treatment of patients infected with a new coronavirus, has jumped into the second stage of developing monoclonal antibody treatment by analyzing and evaluating antibodies in the blood of a cured patient.

To secure therapeutic antibodies and start clinical trials on patients, Celltrion has secured candidates for antibody treatment for a lab experiment to ensure that antibodies can neutralize the new coronavirus.

From April 2, Celltrion said that it embarked on the verification of antibodies to see if they can neutralize the virus in the test tube and started screening the second group of candidate antibodies. The company said it would start clinical tests on animals after finishing the verification process.

"In the process, all available personnel will be mobilized to present products that can be administered to the human body in the shortest period of time," a Celltrion official said. "The entire research team is working hard to find the best candidate material for human clinical administration in July."

The Korea National Institute of Health, a state research body, has selected SK Bioscience and Celltrion as cooperation partners for its project to develop preventive vaccines and medicine. SK Bioscience claimed to have secured a candidate for COVID-19 through the protein culture and refining platform of an antigen produced with gene recombination technology.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .State watchdog starts screening Celltrions antibody treatment for COVID-19.
    State watchdog starts screening Celltrion's antibody treatme…
  • .Celltrion leaves door open for consignment production of COVID-19 vaccines.
    Celltrion leaves door open for consignment production of COV…
  • .GC Pharmas plasma treatment allowed for actual use in treating COVID-19 patients.
    GC Pharma's plasma treatment allowed for actual use in treat…
  • . Celltrion revises deal with U.S. client to ship new rapid COVID-19 antigen test kit.
    Celltrion revises deal with U.S. client to ship new rapid C…
  • .  Celltrion checks antibody treatments effect of COVID-19 infection prevention    .
    Celltrion checks antibody treatment's effect of COVID-19 i…

Real Time Photo News

  • .NCSofts global K-pop fan community platform to service original content including songs.

    NCSoft's global K-pop fan community platform to service original content including songs

  • .Singer IU drops teaser image for upcoming full album.

    Singer IU drops teaser image for upcoming full album

  • .Cube Entertainment partners with web comics company to create online video content.

    Cube Entertainment partners with web comics company to create online video content

  • .Sci-fi film starring Song Joong-ki to be reelased on Netflix in February.

    Sci-fi film starring Song Joong-ki to be reelased on Netflix in February

  • .Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series Criminal Justice.

    Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series 'Criminal Justice'

Latest News

more+

  • Hyundai auto group makes strategic investment in Israeli startup UVeye
  • Moon visits announces potential deal with Novavax for 20 mln people: Yonhap
  • Hyundai shipyard lifts 9,100-ton topside of deep-water offshore plant
  • NCSoft's global K-pop fan community platform to service original content including songs
  • Daewoo shipyard jumps into development of offshore substations for wind farms
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view